Vanguard Personalized Indexing Management
PACB icon

Vanguard Personalized Indexing Management’s Pacific Biosciences PACB Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.3K Sell
25,164
-942
-4% -$1.37K ﹤0.01% 2155
2026
Q1 		$34.5K Sell
26,106
-7,774
-23% -$13.9K ﹤0.01% 2088
2025
Q4 		$63.4K Sell
33,880
-675
-2% -$1.3K ﹤0.01% 1856
2025
Q3 		$44.2K Sell
34,555
-2,191
-6% -$2.97K ﹤0.01% 1911
2025
Q2 		$45.6K Buy
36,746
+6,321
+21% +$7.3K ﹤0.01% 1838
2025
Q1 		$35.9K Buy
30,425
+26
+0.1% +$40 ﹤0.01% 1707
2024
Q4 		$55.6K Buy
30,399
+10,763
+55% +$21K ﹤0.01% 1686
2024
Q3 		$33.4K Buy
19,636
+7,820
+66% +$12.8K ﹤0.01% 1712
2024
Q2 		$16.2K Buy
+11,816
New +$23.9K ﹤0.01% 1668

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Personalized Indexing Management's PACB Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Pacific Biosciences (PACB) stake by 3.6% in Q2 2026, selling an estimated $1.37K and leaving 25,164 shares worth $42.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2155.

Vanguard Personalized Indexing Management first reported a position in PACB in Q2 2024 and has held it in 9 quarters since. The position peaked at $63.4K in Q4 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Vanguard Personalized Indexing Management held 25,164 shares of Pacific Biosciences worth $42.3K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 942 Pacific Biosciences shares in Q2 2026, an estimated $1.37K.
  • Pacific Biosciences made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2155 holding.
  • Vanguard Personalized Indexing Management first reported a position in Pacific Biosciences in Q2 2024 and has held it in 9 quarters since.
  • Vanguard Personalized Indexing Management's Pacific Biosciences position peaked at $63.4K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.